Vascular Dementia Treatment Market to Grow at Highest Pace Owing to Increasing Research and Development Activities

 

The Vascular Dementia Treatment market is witnessing significant growth owing to the rising prevalence of cerebrovascular conditions and growing geriatric population globally. Vascular dementia or Vascular cognitive impairment refers to decline in thinking skills caused by brain damage from impaired blood flow to the brain. It is one of the most common forms of dementia after Alzheimer's disease. The condition accounts for approximately 20% of all dementia cases. Symptoms of vascular dementia include difficulties with planning and organizing tasks, problems with memory or concentration, mood or behavioral changes, and trouble with language. Key therapies and medications used for treatment include cholinesterase inhibitors such as donepezil, memantine, antiplatelet and anticoagulant drugs to prevent further strokes, and lifestyle changes like exercise, diet control, and management of risk factors like diabetes and hypertension.

The global Vascular Dementia Market is estimated to be valued at US$ 259.3 million in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024-2030. Key players operating in the Vascular Dementia Treatment market are Pfizer, Johnson & Johnson, Daiichi Sankyo, Eisai, Lundbeck, Novartis, Allergan, Takeda Pharmaceutical, and Merz Pharma.

Key Takeaways

- Key players operating in the Vascular Dementia Treatment market are Pfizer, Johnson & Johnson, Daiichi Sankyo, Eisai, Lundbeck, Novartis, Allergan, Takeda Pharmaceutical, and Merz Pharma. These players account for a majority share of the global market.

- Increasing prevalence of cerebrovascular diseases like strokes and cardiovascular disease is a major factor fueling the demand for effective treatment of vascular dementia. As per estimates, over 17 million people suffer stroke each year globally.

- Development of advanced neuroimaging techniques for early and accurate diagnosis of vascular cognitive impairment is driving the market growth. Technologies like MRI, CT scans, and PET scans help detect underlying brain damage and pinpoint treatment plans accordingly.

Market Trends

- Increasing research towards developing disease-modifying therapies: Major pharmaceutical manufacturers are investing heavily in research to discover drugs that can halt or slow the progression of dementia caused by impaired blood circulation. Some potential targets under investigation include amyloid and tau proteins.

- Combination therapies gaining traction: Since vascular dementia often co-occurs with Alzheimer's disease, clinical trials are exploring the benefits of combining cholinesterase inhibitors and memantine with antihypertensive or statin drugs. A combination approach may yield better outcomes.

Market Opportunities

- Emerging economies in Asia Pacific and Latin America present high growth potential for vascular dementia treatment drugs and devices. Aging demographics and rising healthcare expenditure will augment the demand.

- Developing novel diagnostic tools through cutting-edge technologies like digital markers will help detect vascular cognitive impairment at an early pre-dementia stage. This presents an opportunity to intervene proactively and slow disease progression.

Impact of COVID-19 on Vascular Dementia Market Growth

The outbreak of COVID-19 pandemic significantly impacted the growth of the global vascular dementia market. Lockdowns imposed across various countries disrupted the supply chain and slowed down the production of effective drugs and therapeutics required for the treatment of vascular dementia. Furthermore, restrictions on non-essential medical services diverted the healthcare resources towards tackling the rising COVID cases. This halted the diagnosis and treatment of numerous neurological disorders including vascular dementia.

During the pre-COVID times, the market was growing at a steady pace owing to the increasing geriatric population succumbing to age-related cognitive disorders. However, the pandemic massively hindered the market growth in 2020. With lockdowns in place, patients avoided hospital visits and deferred their treatment plans due to the fear of virus exposure. This led to underdiagnosis of dementia cases globally.

As the world is gradually recovering from the pandemic crisis, the market is anticipated to regain its momentum backed by increasing research funding to develop more effective therapeutic options. Moreover, healthcare systems are better prepared with sufficient resources to handle non-COVID cases while taking necessary precautions. Telemedicine and online consultations are also helping patients to continue their treatment from home. Pharmaceutical companies are expediting their clinical trials. The rising awareness about vascular dementia and availability of new drugs are expected to boost the market in the coming years.

Prominent Regions for Vascular Dementia Market

North America represents the most lucrative region for the vascular dementia market in terms of value. This is majorly attributed to the growing geriatric population prone to neurological complications. Favorable reimbursement policies along with presence of advanced healthcare infrastructure support early diagnosis and treatment in the region.

Asia Pacific is identified as the fastest growing regional market for vascular dementia. This is driven by improving economic conditions, increasing healthcare spending, rising medical tourism, growing awareness about age-related cognitive issues and expanding patient pool in developing countries like China and India. Initiatives taken by governments to enhance dementia care are further contributing to the market growth in Asia Pacific.

Get more insights on this topic : https://nouw.com/ajay100/vascular-dementia-market-is-estimated-to-witness-high-growth-owing-to-rising-prevalence-of-stroke-38617278

What Are The Key Data Covered In This Vascular Dementia  Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Vascular Dementia 's growth between 2024 and 2031.

:- Accurate calculation of the size of the Vascular Dementia  and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- Vascular Dementia  Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Vascular Dementia  vendors

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it